SHILPAMED Shilpa Medicare Ltd Expansion Plans Announcement 2025 - EMA Approval Granted Shilpa Medicare Ltd's Unit VI in Bengaluru has received GMP approval from the European Medicines Agency, allowing it to manufacture complex dosage forms like Oral Mouth Dissolving Films and Transdermal Systems for the European market, following an inspection conducted from March 10-14, 2025..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Shilpa Medicare Ltd